Hands down one of the lowest valued pharma co's in our stock market. The co has great visibility and cash flow generation from their business upto 2025. The company is also looking at actively growing in both pharma & agro chems.
The co has formed an excellent base and could now be seen breaking out with large volumes from the base Long at current price with stoploss below 619.
Expecting to see this co making some noise in the M&A space in FY24.
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.